NCT01585246View on ClinicalTrials.gov

Saw Palmetto: Symptom Management for Men During Radiation Therapy

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions
Prostate Cancer
Interventions
DRUG

Saw Palmetto

1 of 3 doses of Saw Palmetto (320, 640, 960mg/day)

DRUG

soybean oil soft gel

placebo (soybean oil soft gel)

Trial Locations (6)

48043

McLaren Macomb, Mount Clemens

48341

St. Joseph Mercy Oakland Hospital, Pontiac

48858

McLaren Central Michigan, Mount Pleasant

48910

McLaren Greater Lansing, Lansing

48912

Sparrow Cancer Center, Lansing

49201

Allegiance Health, Jackson

All Listed Sponsors
lead

Michigan State University

OTHER

NCT01585246 - Saw Palmetto: Symptom Management for Men During Radiation Therapy | Biotech Hunter | Biotech Hunter